INO-5401 + INO-9012 in Combination With Atezolizumab in Locally Advanced Unresectable or Metastatic/Recurrent Urothelial Carcinoma

NCT03502785 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Urothelial Carcinoma

Interventions

BIOLOGICAL: INO-5401
BIOLOGICAL: INO-9012
DRUG: Atezolizumab
DEVICE: CELLECTRA™ 2000

Sponsor

Inovio Pharmaceuticals